Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

被引：0
|
作者：
Shuai Xia
Jasper Fuk-Woo Chan
Lijue Wang
Fanke Jiao
Kenn Ka-Heng Chik
Hin Chu
Qiaoshuai Lan
Wei Xu
Qian Wang
Chao Wang
Kwok-Yung Yuen
Lu Lu
Shibo Jiang
机构：
[1] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity
[2] The University of Hong Kong,State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine
[3] The University of Hong Kong-Shenzhen Hospital,Department of Clinical Microbiology and Infection Control
[4] Hong Kong Science and Technology Park,Centre for Virology, Vaccinology and Therapeutics
[5] Beijing Institute of Pharmacology and Toxicology,State Key Laboratory of Toxicology and Medical Countermeasures
来源：
Cell Research | 2022年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：404 / 406
页数：2
相关论文
共 50 条
  • [41] Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
    Altarawneh, Heba N.
    Chemaitelly, Hiam
    Hasan, Mohammad R.
    Ayoub, Houssein H.
    Qassim, Suelen
    AlMukdad, Sawsan
    Coyle, Peter
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Benslimane, Fatiha M.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar H.
    Latif, Ali N.
    Shaik, Riyazuddin M.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed G.
    Butt, Adeel A.
    Al-Romaihi, Hamad E.
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Tang, Patrick
    Abu-Raddad, Laith J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13): : 1288 - 1290
  • [42] Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection
    Maiti, Biplab K.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (04) : 783 - 785
  • [43] Development of multi-epitope peptide-based vaccines against SARS-CoV-2
    Lim, Hui Xuan
    Lim, Jianhua
    Jazayeri, Seyed Davoud
    Poppema, Sibrandes
    Poh, Chit Laa
    BIOMEDICAL JOURNAL, 2021, 44 (01) : 18 - 30
  • [44] Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
    Kalita, Parismita
    Padhi, Aditya K.
    Zhang, Kam Y. J.
    Tripathi, Timir
    MICROBIAL PATHOGENESIS, 2020, 145
  • [45] Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
    Wanbo Tai
    Benjie Chai
    Shengyong Feng
    Xinyu Zhuang
    Jun Ma
    Mujia Pang
    Lin Pan
    Zi Yang
    Mingyao Tian
    Gong Cheng
    Signal Transduction and Targeted Therapy, 7
  • [46] A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV
    Guan, Xiaoqing
    Verma, Abhishek K.
    Wang, Gang
    Roy, Abhijeet
    Perlman, Stanley
    Du, Lanying
    VACCINES, 2024, 12 (06)
  • [47] Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
    Tai, Wanbo
    Chai, Benjie
    Feng, Shengyong
    Zhuang, Xinyu
    Ma, Jun
    Pang, Mujia
    Pan, Lin
    Yang, Zi
    Tian, Mingyao
    Cheng, Gong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [48] Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
    Lee, Richard Kuan-Lin
    Li, Tian-Neng
    Chang, Sui-Yuan
    Chao, Tai-Ling
    Kuo, Chun-Hsien
    Pan, Max Yu-Chen
    Chiou, Yu-Ting
    Liao, Kuan-Ju
    Yang, Yi
    Wu, Yi-Hsuan
    Huang, Chen-Hao
    Juan, Hsueh-Fen
    Hsieh, Hsing-Pang
    Wang, Lily Hui-Ching
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [49] PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
    Jingyi Su
    Jing Zheng
    Wei Huang
    Yali Zhang
    Cairui Lv
    Baoding Zhang
    Lina Jiang
    Tong Cheng
    Quan Yuan
    Ningshao Xia
    Jianming Zhang
    Li Li
    Li Li
    Xianming Deng
    Signal Transduction and Targeted Therapy, 7
  • [50] PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
    Su, Jingyi
    Zheng, Jing
    Huang, Wei
    Zhang, Yali
    Lv, Cairui
    Zhang, Baoding
    Jiang, Lina
    Cheng, Tong
    Yuan, Quan
    Xia, Ningshao
    Zhang, Jianming
    Li, Li
    Li, Li
    Deng, Xianming
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
12345